Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of spontaneous subarachnoid haemorrhage
执笔作者单位：[1]Department of Neurology, Huashan Hospital,Fudan University, Shanghai, China[2]Department of Neurology, The First Hospital of Jilin University, Jilin, China[3]Department of Neurology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China[4]Neurosurgery, Fudan University Huashan Hospital Department of Neurosurgery, Shanghai, China[5]China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China[6]State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Institutes of Brain Science, Fudan University, Shanghai, China
刊名：
ISSN：
年份：
卷：
期：
页码：
DOI：
摘要：
Aim Spontaneous subarachnoid haemorrhage (SAH) caused by ruptured cerebral aneurysm is a severe subtype of haemorrhagic stroke. Although the incidence of SAH is relatively low among all cerebrovascular diseases, the mortality is the highest. The critical management of SAH is challenging. We provide this evidence-based guideline to present current and comprehensive recommendations for the diagnosis and treatment of non-trauma SAH. Methods A formal literature search of MEDLINE (1 January 1990-30 June 2019) was performed. Data were synthesised with the use of evidence tables. Writing group members met by teleconference to discuss data-derived recommendations. The Chinese Stroke Association's levels of evidence grading algorithm was used to grade each recommendation. The guideline draft was reviewed by Chinese Stroke Association's Stroke Fellow Committees. It is intended that this guideline be fully updated every 3 years. Results Evidence-based guidelines are presented for the care of patients presenting with non-trauma SAH. The focus of the guideline was subdivided into transfer and systems of care, diagnosis flowchart, aetiology and differentiation, prevention of rebleeding, surgical and endovascular repair of ruptured aneurysms, management of vasospasm and delayed cerebral ischaemia, management of hydrocephalus, management of seizures and management of medical complications. Conclusions The guideline offers a framework for SAH management. Early professional and aggressive care of SAH might help dramatically.
基金：
Chinese Stroke Association Guidelines Writing Committee
Yi Yang
（Department of Neurology, The First Hospital of Jilin University, Jilin, China）
Yongjun Wang
（Department of Neurology,Beijing Tiantan Hospital, Capital Medical University, Beijing, China）
Liping Liu
（Department of Neurology,Beijing Tiantan Hospital, Capital Medical University, Beijing, China）
Yilong Wang
（Department of Neurology,Beijing Tiantan Hospital, Capital Medical University, Beijing, China）
Xingquan Zhao
（Department of Neurology,Beijing Tiantan Hospital, Capital Medical University, Beijing, China）
Jizong Zhao
（Department of Neurosurgery,Beijing Tiantan Hospital, Capital Medical University, Beijing, China）
Shuo Wang
（Department of Neurosurgery,Beijing Tiantan Hospital, Capital Medical University, Beijing, China）
Anding Xu
（Department of Neurology and Stroke Center, the First Affiliated Hospital, Jinan University, Guangzhou, China）
Kangning Chen
（Department of Neurology, The Southwest Hospital, the First Affiliated Hospital of Third Military Medical University, Chongqing, China）
Junbo Ge
（Shanghai Institute of Cardiovascular Diseases, Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, China）
Li Guo
（Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, China）
Li He
（Department of Neurology, West China Hospital, Sichuan University, Chengdu, China）
Bo Hu
（Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (HUST), Wuhan, China）
Yong Huo
（Department of Cardiology, Peking University First Hospital, Beijing, China）
Linong Ji
（Department of Endocrinology and Metabolism, Peking University People's Hospital, Medicine at Peking University, Beijing, China）
Xunming Ji
（Department of Neurosurgery, Xuanwu Hospital, Capital University of Medicine, Beijing, China）
Tielin Li
（Zhujiang Hospital of Southern Medical University, Guangzhou, China）
Benyan Luo
（Department of Neurology, 1st Affiliated Hospital of Zhejiang University, Hangzhou, China）
Zhongrong Miao
（Department of Interventional Neuroradiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China）
Xiaoyuan Niu
（Department of Neurology, First Hospital of Shanxi Medical University, Taiyuan, China）
Bin Peng
（Department of Neurology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China）
Dingfeng Su
（Department of Pharmacology, the Second Military Medical University (SMMU), Shanghai, China）
Beisha Tang
（Department of Neurology, Xiangya Hospital, Central South University, Changsha, China）
Chen Wang
（Beijing Tiantan Hospital, Capital Medical University, Beijing, China）
Ning Wang
（Department of Neurology and Institute of Neurology, First Affiliated Hospital of Fujian Medical University, Fuzhou, China）
Wei Wang
（Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China）
Xin Wang
（Department of Neurology, Zhongshan Hospital, Fudan University, Shanghai, China）
Shizheng Wu
（Qinghai Province People's Hospital, Xining, China）
Peng Xie
（Chongqing Medical University (CQMU), Chongqing, China）
Yuming Xu
（Department of Neurology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China）
Yun Xu
（Department of Neurology, Drum Tower Hospital, Medical School of Nanjing University, Nanjing, China）
Yi Yang
（Department of Neurology, the First Hospital of Jilin University, Changchun, China）
Jinsheng Zeng
（Department of Neurology and Stroke Center, the First Affiliated Hospital of Sun Yat-Sen University, Guangdong, China）
Chaodong Zhang
（The First affiliated Hospital of China Medical University, Shenyang, China）
Tong Zhang
（Capital Medical University School of Rehabilitation Medicine, China Rehabilitation Research Center, Beijing, China）
Zhuo Zhang
（Beijing Anzhen Hospital, Capital Medical University, Beijing, China）
Gang Zhao
（Department of Neurology, Xijing Hospital, The 4th Military Medical University, Xi’an, China）
Xingquan Zhao
（Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China）
本院专家组成员：
Wei Wang[27]
（Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China）
Yi Dong,Zhen-Ni Guo,Qi Li,et al.Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of spontaneous subarachnoid haemorrhage[J].STROKE AND VASCULAR NEUROLOGY.2019,4(4):176-181.
APA：
Yi Dong,Zhen-Ni Guo,Qi Li,Wei Ni,Hongqiu Gu...&Chinese Stroke Association Stroke Council Guideline Writing Committee.(2019).Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of spontaneous subarachnoid haemorrhage.STROKE AND VASCULAR NEUROLOGY,4,(4)
MLA：
Yi Dong,et al."Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of spontaneous subarachnoid haemorrhage".STROKE AND VASCULAR NEUROLOGY 4..4(2019):176-181
